We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Closing Statements Begin in Trial of Elizabeth Holmes’s Ex-Boyfriend
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Technology > Closing Statements Begin in Trial of Elizabeth Holmes’s Ex-Boyfriend
Closing Statements Begin in Trial of Elizabeth Holmes’s Ex-Boyfriend
Technology

Closing Statements Begin in Trial of Elizabeth Holmes’s Ex-Boyfriend

Last updated: June 21, 2022 6:00 pm
Editorial Board Published June 21, 2022
Share
SHARE
00balwani closing facebookJumbo

For months, Ramesh Balwani’s lawyers have tried to distinguish him from Elizabeth Holmes, his former girlfriend and business partner at the failed blood-testing company Theranos.

Ms. Holmes was found guilty of defrauding the start-up’s investors in January. Mr. Balwani is seeking a different outcome in his own fraud trial.

But on Tuesday, in closing statements for Mr. Balwani’s trial, prosecutors tied him directly to Ms. Holmes and the yearslong fraud at Theranos. Jeffrey Schenk, an assistant U.S. attorney and a lead prosecutor on the case, displayed a text message that Mr. Balwani sent Ms. Holmes in 2015 that was used as evidence in the trial.

“I am responsible for everything at Theranos,” Mr. Balwani wrote. “All have been my decisions too.”

The text message was an admission of guilt, Mr. Schenk said, adding, “He’s acknowledging his role in the fraud.”

The presentation capped more than three months of testimony in Mr. Balwani’s trial, which largely mirrored that of Ms. Holmes’s last fall. Ms. Holmes and Mr. Balwani, 57, were charged in 2018 for exaggerating the capabilities of Theranos’s blood-testing machines and business performance when, in fact, the products did not work and its business was struggling. The duo pleaded not guilty. Ms. Holmes was convicted on four of 11 charges.

The trial for Mr. Balwani, who is known as Sunny, lacked the fanfare of Ms. Holmes’s high-profile case. It nonetheless serves as a coda to a waning era of start-up growth that often relied on hype and hyperbole. Ms. Holmes and Mr. Balwani are among the very few tech executives who have ever been prosecuted for fraud.

Just as Ms. Holmes tried blaming others for the deceptions at Theranos, Mr. Balwani has pointed the finger back at her. Throughout the trial, his lawyers argued that many of Theranos’s blood tests had worked. And they said that Ms. Holmes controlled Theranos, not Mr. Balwani. They were set to begin their closing argument later on Tuesday.

Ms. Holmes, now 38, met Mr. Balwani when she was 18. They began dating years later, after Ms. Holmes had founded Theranos. In 2009, Mr. Balwani invested in Theranos and became its chief operating officer, eventually taking charge of its lab. The pair kept their relationship a secret and lived together in a sprawling home they co-owned in Atherton, Calif.

In 2016, after Theranos came under fire for lying about its blood testing capabilities, Mr. Balwani left the company and split with Ms. Holmes. The pair were charged with fraud together, but Ms. Holmes argued in filings to sever the cases and accused Mr. Balwani of emotional and sexual abuse. Her trial included dramatic testimony recounting the accusations. That subject was excluded from Mr. Balwani’s trial.

To convict Mr. Balwani, prosecutors must convince jurors that he intentionally lied to investors and patients about Theranos’s blood tests and business dealings.

Prosecutors tried blaming Mr. Balwani for financial projections that Theranos showed to investors and the condition of its labs. New witnesses included investors and executives who dealt directly with Mr. Balwani, rather than Ms. Holmes.

One projection, presented to investors in October 2014, showed Theranos would bring in $140 million that year. In reality, revenue was limited. The next year, Mr. Balwani projected nearly $1 billion in revenue in pitches to investors. Theranos’s internal projections were much lower, evidence showed, and the reality was closer to zero.

A new witness, Patrick Mendenhall, who dealt directly with Mr. Balwani while making an investment in Theranos, outlined the promises made that turned out to be misleading or false.

Brian Grossman, an investor at the hedge fund PFM Health Sciences, who was also a witness in Ms. Holmes’s trial, testified that Mr. Balwani provided his team with financial projections that far overstated Theranos’s projected revenue.

“When Mr. Balwani communicates with an investor, it’s for a purpose, and the purpose is to deceive them to get money,” Mr. Schenk said.

Prosecutors also emphasized Mr. Balwani’s role in running Theranos’s lab, which the executive had called a “disaster zone” in a 2014 text message used as evidence. Mr. Balwani would also “remove dissent” by intimidating or pushing out employees who expressed concern about Theranos tests, like Dr. Adam Rosendorff, a former lab director who testified in both trials, Mr. Schenk said

Notably absent from the witness stand were James Mattis, a former defense secretary and Theranos board member, and Ms. Holmes, who had both testified in Ms. Holmes’s trial. Mr. Balwani did not testify in his own defense.

If convicted, Mr. Balwani and Ms. Holmes will be sentenced together in September.

You Might Also Like

AWS unveils Bedrock AgentCore, a brand new platform for constructing enterprise AI brokers with open supply frameworks and instruments

Claude Code income jumps 5.5x as Anthropic launches analytics dashboard

Mira Murati says her startup Pondering Machines will launch new product in ‘months’ with ‘significant open source component’

OpenAI, Google DeepMind and Anthropic sound alarm: ‘We may be losing the ability to understand AI’

Mistral’s Voxtral goes past transcription with summarization, speech-triggered capabilities

TAGGED:Balwani, RameshComputers and the InternetFrauds and SwindlingHolmes, Elizabeth (1984- )Silicon Valley (Calif)Start-upsTests (Medical)The Washington MailTheranos Inc
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Nintendo fiscal yr gross sales drop 30% forward of Swap 2 launch
Technology

Nintendo fiscal yr gross sales drop 30% forward of Swap 2 launch

Editorial Board May 8, 2025
Mistral’s new Codestral code completion mannequin races up third-party charts
Tems took Nigeria to Beyoncé and Rihanna. Now, she’s up for 3 Grammys
Coast Guard Admiral to Become First Female Service Chief, Shattering Another Glass Ceiling
Ukraine Live Updates: As a Province Falls, Russian Forces Can Focus Farther West

You Might Also Like

Google research exhibits LLMs abandon right solutions beneath strain, threatening multi-turn AI methods
Technology

Google research exhibits LLMs abandon right solutions beneath strain, threatening multi-turn AI methods

July 16, 2025
Lastly, a dev equipment for designing on-device, cell AI apps is right here: Liquid AI’s LEAP
Technology

Lastly, a dev equipment for designing on-device, cell AI apps is right here: Liquid AI’s LEAP

July 15, 2025
Lastly, a dev equipment for designing on-device, cell AI apps is right here: Liquid AI’s LEAP
Technology

Perplexity gives free AI instruments to college students worldwide in partnership with SheerID

July 15, 2025
Lastly, a dev equipment for designing on-device, cell AI apps is right here: Liquid AI’s LEAP
Technology

Anthropic launches finance-specific Claude with built-in information connectors, increased limits and immediate libraries

July 15, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?